Publicaciones en las que colabora con Luis Miguel Blanco Colio (10)

2016

  1. Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential

    Expert Review of Proteomics, Vol. 13, Núm. 9, pp. 857-871

2013

  1. Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice

    PLoS ONE, Vol. 8, Núm. 12

2011

  1. Animal models of cardiovascular diseases

    Journal of Biomedicine and Biotechnology, Vol. 2011

2008

  1. Proteomics in atherosclerosis

    Current Atherosclerosis Reports, Vol. 10, Núm. 3, pp. 209-215

2007

  1. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques

    European Journal of Pharmacology, Vol. 562, Núm. 1-2, pp. 119-129

2006

  1. Modulación mediante tratamiento con atorvastatina y/o amlodipino del perfil de proteínas liberadas por placas ateroscleróticas humanas

    Clínica e investigación en arteriosclerosis, Vol. 18, Núm. 5, pp. 167-175

2005

  1. Quest for novel cardiovascular biomarkers by proteomic analysis

    Journal of Proteome Research, Vol. 4, Núm. 4, pp. 1181-1191

2003

  1. Simvastatin reduces NF-κB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

    Cardiovascular Research, Vol. 57, Núm. 1, pp. 168-177

2002

  1. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells

    Atherosclerosis, Vol. 160, Núm. 1, pp. 49-58

2001

  1. Simvastatin reduces inflammation in rabbit atheroma more markdely than dietary lipid lowering

    Investigacion Cardiovascular, Vol. 4, Núm. 1, pp. 28-42